Purchase of Aflibercept

This tender covers the purchase of Aflibercept, an ophthalmological drug used for treating eye conditions such as wet age-related macular degeneration. The buyer is a Belgian healthcare institution, likely a hospital or public health authority, serving patients requiring this medication. The notice does not specify volume or duration, but it implies a recurring procurement for a specific branded or generic drug. No unusual qualifications or set-asides are mentioned; the requirement appears straightforward for pharmaceutical supply.